FDA Approves Changes to Kaletra Label
"On January 28, [2015] FDA approved changes to the Kaletra (lopinavir/ritonavir) label to include dosing recommendations in pregnant women."
More information is available:
FDA: Press release
AIDSinfo: Patient fact sheet on Kaletra
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - Category: Infectious Diseases Source Type: news
More News: Department of Health | Health | HIV AIDS | Infectious Diseases | Kaletra | Norvir | Pregnancy | Women